10x Genomics, Inc. is trading 5.2% down today at $29.43, continuing a sharp pullback after a strong rebound from late May lows.
- The decline follows a roughly 7% drop on June 5 driven by profit-taking and mean reversion after a multi-day rally.
- No new company-specific news or guidance changes have been reported, suggesting the move is primarily technical in nature.
- The stock's downward momentum persists despite a broadly firmer overall market.